Radiologically isolated syndrome
Radiologically Isolated Syndrome (RIS) is a condition identified by the presence of lesions in the central nervous system, similar to those seen in Multiple Sclerosis (MS), in individuals who do not exhibit any symptoms of the disease. The condition is often discovered incidentally during magnetic resonance imaging (MRI) scans conducted for other reasons.
Definition[edit]
Radiologically Isolated Syndrome is defined by the incidental discovery of anomalies in the brain and/or spinal cord that are characteristic of Multiple Sclerosis, in the absence of any related symptoms or neurological findings. These anomalies are typically identified during MRI scans conducted for unrelated reasons.
Epidemiology[edit]
The exact prevalence of RIS is unknown, as the condition is often discovered incidentally. However, studies suggest that the condition is more common in females and individuals aged between 30 and 40 years.
Clinical Presentation[edit]
Individuals with RIS do not exhibit any symptoms. The condition is often discovered during MRI scans conducted for other reasons. However, some individuals may eventually develop symptoms of Multiple Sclerosis.
Diagnosis[edit]
The diagnosis of RIS is based on the presence of anomalies in the brain and/or spinal cord that are characteristic of Multiple Sclerosis, in the absence of any related symptoms or neurological findings. These anomalies are typically identified during MRI scans conducted for unrelated reasons.
Management[edit]
The management of RIS is primarily observational, with regular MRI scans to monitor the progression of the condition. Some studies suggest that early treatment with disease-modifying therapies may delay the onset of Multiple Sclerosis symptoms in individuals with RIS.
Prognosis[edit]
The prognosis of RIS is variable. Some individuals may never develop symptoms of Multiple Sclerosis, while others may go on to develop the disease.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
